Endoscopic palliation of oesophageal cancer: Results of a prospective comparison of Nd : YAG laser and ethanol injection

Citation
A. Carazzone et al., Endoscopic palliation of oesophageal cancer: Results of a prospective comparison of Nd : YAG laser and ethanol injection, EURO J SURG, 165(4), 1999, pp. 351-356
Citations number
25
Categorie Soggetti
Surgery
Journal title
EUROPEAN JOURNAL OF SURGERY
ISSN journal
11024151 → ACNP
Volume
165
Issue
4
Year of publication
1999
Pages
351 - 356
Database
ISI
SICI code
1102-4151(199904)165:4<351:EPOOCR>2.0.ZU;2-2
Abstract
Objective: To evaluate the effectiveness of intratumoral alcohol injection compared with Nd:YAG laser in the treatment of unresectable fungating cance rs of the oesophagus. Design: Prospective, randomised clinical study. Setting: University hospital, Italy. Subjects and interventions: 47 consecutive patients were randomly allocated to have endoscopic Nd:YAG laser treatment (n = 24), or intratumoural injec tion of 98% alcohol (n = 23). Main outcome measures: Morbidity, mortality, dysphagia score, survival. Results: One patient in the laser group needed analgesic support during and after the treatment, whereas 18 (78%) of those treated with alcohol experi enced mild pain and most of them required analgesics. An improvement of at least 2 points in the dysphagia score was noted in 21 patients (88%) in the laser group and in 18 in the alcohol group (78%). The mean dysphagia-free intervals between each treatment were 30 and 37 days, respectively. The med ian survival was 6 months in each group. There were no significant differen ces in the mean dysphagia scores of patients still alive. There were no com plications in the laser group, but one oesophageal perforation occurred dur ing the preliminary dilatation before the second session of alcohol injecti on. There were no procedure-related deaths. Conclusion: The two techniques allowed similar palliation of dysphagia and improvement of quality of life. Intratumoral injection of alcohol is an eff ective and inexpensive therapeutic option in the palliation of fungating oe sophageal lesions.